Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(37)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Sep 28, 2024 3:29am
RE:Financing
GPM is the only active ingredient that works really well. Everything else has failed or is selling badly (tfc1067). I would rather wait longer (smaller product launch and possible supply bottlenecks
...more
(1957)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Sep 27, 2024 7:48pm
Financing
SBM "management" has claimed they have been trying to get non-dilutive financing, but we all know that is a fantasy. If they are going to do a share issue, it would be nice if they
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Sep 27, 2024 4:04pm
RE:RE:RE:RE:RE:Interview with the vampire
Howie already proven he will dilute at 0.10. as per his most recent failed attempt. Again, not even a passing nod to the SkinMedica. He always pumps the next molecule after failure with the last
...more
(69)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Sep 27, 2024 3:19pm
RE:RE:RE:RE:Interview with the vampire
The crappy interview was published in a new channel so I guess we gained a few additional fellow shareholders. Hence the higher shareprice. Please put Geraldine front and center instead, if the
...more
(82)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Sep 27, 2024 3:04pm
RE:RE:RE:Interview with the vampire
That was definitely an awkward interview. They really need someone more polished and adept at public speaking representing them. It's a skill like anything else that needs practice and
...more
(9)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Sep 27, 2024 12:25pm
RE:RE:Interview with the vampire
Oh my goodness!! Game over, Howard and the other clown's. What a bullshit interview. A graduate could have a better performance. :-) we can see the desperation in Howard's face.
(69)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Sep 27, 2024 11:52am
RE:Interview with the vampire
Well, someone has to learn him how to dress properly... not so much CEO-material in Howard.
(1)
•••
Nitrodouglas
X
View Profile
View Bullboard History
Post by
Nitrodouglas
on Sep 27, 2024 11:13am
Interview with the vampire
https://cdn.jwplayer.com/previews/9bNZ6LWDStockhouse CEO Interview
(1383)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Sep 27, 2024 12:37am
RE:RE:LACK OF TRUST AND INVESTOR CONFIDENCE
Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics GlobeNewswire June 13, 2022 So it has been 27 months since the Allergen deal was announced. What is
...more
(13)
•••
doonery
X
View Profile
View Bullboard History
Comment by
doonery
on Sep 26, 2024 3:59pm
RE:21 day trial or 3 month trial?
good luck hearing back from chris,,,
(1)
•••
Nitrodouglas
X
View Profile
View Bullboard History
Post by
Nitrodouglas
on Sep 26, 2024 10:25am
21 day trial or 3 month trial?
So Sirona is poised to launch the 21 day intensive serum first as given in the update. I asked Chris if this will require a 21 day trial or a 3 month trial. Big difference in timing and money I'm
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Sep 26, 2024 8:29am
Buzz on the Bullboards: TSX stocks making headlines this week
The TSX experienced a dynamic week. It opened flat Monday, but saw a significant jump Tuesday driven by an increase in commodity prices.
read article.
(4)
•••
bazooka73
X
View Profile
View Bullboard History
Comment by
bazooka73
on Sep 26, 2024 1:46am
RE:RE:LACK OF TRUST AND INVESTOR CONFIDENCE
I have to agree with MWM. On the occasion of the AbbVie deal, Howie already ‘promised’ that Sirona would become profitable. Since then, exactly nothing has happened. On the contrary, they are
...more
(69)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Sep 26, 2024 12:51am
RE:RE:LACK OF TRUST AND INVESTOR CONFIDENCE
I'm not defending Howard, but what you suggest is simply not true. Yes, Howard has stated that the Abbvie deal revenue should make the company profitable. The management claims they are
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Sep 25, 2024 3:43pm
RE:LACK OF TRUST AND INVESTOR CONFIDENCE
Howie said that the GlycoP launch in 2025 could possibly bring profitability, not the AbbVie deal. Suggesting there is not alot of money expected from SkinMedica. Barely a paragraph of a
...more
(85)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Sep 25, 2024 2:52pm
LACK OF TRUST AND INVESTOR CONFIDENCE
It's evident by only trading about 50 thousand shares so far today that most investors are reluctant to yet believe management, in spite of the press release sounding very positive. In the good
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Topgolf Takes Fortnite by Storm – Gamers Can Now Swing, Score, and Win Big in the Virtual World